Comparing the current results to its competitors, Ir Med Inc reported Revenue decrease in the 2 quarter 2025 year on year by 0 %, despite the revenue increase by the most of its competitors of 7.83 %, recorded in the same quarter.
Ir Med Inc 's Comment on Competition and Industry Peers
The company operates in competitive medical device market segments, facing competition from commercial medical device companies, academic institutions, government agencies, and private and public research organizations. Competitors often have greater financial resources, product development capabilities, manufacturing capacity, and marketing expertise. Large medical device companies possess extensive experience in clinical testing and regulatory approval processes and compete for scientific and clinical development personnel. Smaller or early-stage companies may also be competitors, particularly through collaborations with larger firms. The company's PressureSafe™ device is expected to compete directly with Bruin’s Biometrics Provizio SEM Scanner, which is commercially available in the U.S., U.K., and E.U. Bruin’s product utilizes electro-resistance measurement of skin moisture, while PressureSafe™ employs real-time, multi-biomarker optical monitoring combined with AI-based assessment.
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Baxter International Inc is a global healthcare company that specializes in providing a wide range of medical products and services. They operate through various business segments including Pharmaceuticals, Medical Products, and Renal Care, offering solutions for hospitals, clinics, and home-based healthcare settings.
Atricure Inc is a medical device company that focuses on developing, manufacturing, and selling innovative surgical solutions for the treatment of cardiac arrhythmias and other heart-related conditions.
Sources:
Ir med Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Ir med Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
